DAUNOrubicin and Cytarabine and Mogamulizumab-kpkc
Determining the interaction of DAUNOrubicin and Cytarabine and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal), Daunorubicin and Cytarabine (Liposomal)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DAUNOrubicin and Cytarabine-Mogamulizumab-kpkc Intravenous
- DAUNOrubicin and Cytarabine-Molindone
- DAUNOrubicin and Cytarabine-Mometasone (Oral Inhalation)
- DAUNOrubicin and Cytarabine-Mometasone and Formoterol
- DAUNOrubicin and Cytarabine-Mometasone and formoterol Inhalation
- DAUNOrubicin and Cytarabine-Mometasone Cream
- Mogamulizumab-kpkc-Daunorubicin and Cytarabine (Liposomal)
- Mogamulizumab-kpkc-Daunorubicin and cytarabine liposome Intravenous
- Mogamulizumab-kpkc-Daunorubicin citrate
- Mogamulizumab-kpkc-Daunorubicin citrate liposome Intravenous
- Mogamulizumab-kpkc-Daunorubicin hydrochloride
- Mogamulizumab-kpkc-Daunorubicin Intravenous